Printer Friendly

PERSEPTIVE BIOSYSTEMS ANNOUNCES EXERCISE OF PTC II OVER-ALLOTMENT OPTION

 CAMBRIDGE, Mass., Jan. 11 /PRNewswire/ -- PerSeptive Biosystems, Inc. (NASDAQ-NMS: PBIO) announced today that the underwriters of the previously announced public offering of Units of Callable Common Stock of PerSeptive Technologies II Corporation (NASDAQ-NMS: PTCCZ) (PTC II) and one Five Year Warrant to purchase one share of PerSeptive Common Stock have exercised their over-allotment option to purchase an additional 345,000 Units. As a result, gross proceeds of the offering amounted to approximately $58.2 million. The underwriters for the offering were Alex. Brown & Sons and Cowen & Company.
 PerSeptive Biosystems designs, manufactures and markets proprietary products and systems for the purification and analysis of biomolecules. These bioseparations products significantly reduce the time and cost required for the development and manufacture of biopharmaceuticals. Its current and planned products are based on its core technologies: Perfusion Chromatography(R) for high resolution separations of biomolecules 10 to 1,000 times faster than conventional chromatography; ImmunoDetection(TM) for real-time immunoassays in a flow-through cartridge format; Rational Surface Design(TM), synthetic surfaces that bind biomolecules with the high specificity of antibodies; and Mass Spectrometry for high resolution and sensitivity in biomolecular analysis.
 Prospectuses may be obtained from Alex. Brown & Sons Incorporated, 135 E. Baltimore St., Baltimore, MD, 21202, Attn: Michael Ott; or Cowen & Company, Financial Square, 27th Floor, New York, N.Y., 10005, Attn: Jack Dunphy.
 This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
 -0- 1/11/94
 /CONTACT: Robert A. Fein, senior vp-finance of PerSeptive Biosystems, 617-621-1787/
 (PBIO PTCCZ)


CO: PerSeptive Biosystems, Inc.; PerSeptive Technologies II Corporation ST: Massachusetts IN: MTC SU: OFR

DJ-CM -- NE002 -- 0889 01/11/94 09:48 EST
COPYRIGHT 1994 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 11, 1994
Words:312
Previous Article:BARNETT REPORTS RECORD EARNINGS AND RETURN ON ASSETS
Next Article:DYNAMIC CLASSICS, LTD. ANNOUNCES EARNINGS OF $.23 PER SHARE FOR THE 2ND QUARTER VERSUS $.04 PER SHARE FOR THE PREVIOUS 2ND QUARTER
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters